Case number 1:19-cv-00223
Genentech, Inc. et al v. Aizant Drug Research Solutions Pvt. Ltd. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 9, 2020 | 1 | Complaint (40) |
| Jan 7, 2020 | 19 | Patent/Trademark Report to Commissioner (2) |
| Jan 7, 2020 | 19 | Main Document (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,566,729 B1; 7,635,707 B1; 7,767,700 B2; 7,816,383 B1; 7,910,610 B1; 8,013,002 B2; 8,084,475 B2; 8,318,780 B2; 8,383,150 B2; 8,420,674 B2; 8,592,462 B2; 8,609,701 B2; 8,648,098 B2; 8,754,109 B2; 8,778,947 B2. (Attachments: # (1) Order (D.I. 92 in Lead Civil Action 19-78-RGA))(nms) |
| Jan 7, 2020 | 19 | Order (D.I. 92) (2) |
| Jan 2, 2020 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per entry of D.I. 92 in Lead Civil Action 19-78-RGA. (nms) |
| Sep 16, 2019 | 18 | Transcript (41) Docket Text: Official Transcript of Scheduling Conference held on 08/20/19 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather M. Triozzi,Telephone number 302-573-6195. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 10/7/2019. Redacted Transcript Deadline set for 10/17/2019. Release of Transcript Restriction set for 12/16/2019. (Triozzi, Heather) |
| Sep 5, 2019 | 17 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Aizant Drug Research Solutions Pvt. Ltd.s Initial ESI Disclosures and Aizant Drug Research Solutions Pvt. Ltd.s Initial Disclosures Pursuant to Rule 26(a)(1) filed by Aizant Drug Research Solutions Pvt. Ltd..(Stamoulis, Stamatios) |
| Sep 3, 2019 | 16 | Scheduling Order (16) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Fact Discovery completed by 11/12/2020. Joint Claim Construction Brief due by 8/26/2020. A Markman Hearing is set for 9/23/2020, at 8:30 AM in Courtroom 6A. A Pretrial Conference is set for 10/22/2021, at 8:30 AM in Courtroom 6A. A Bench Trial is set for 11/8/2021, at 9:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 8/30/2019. Associated Cases: 1:19-cv-00078-RGA et al.(nms) |
| Sep 3, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Sherry R. Fallon for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:19-cv-00078-RGA et al.(cak) |
| Aug 30, 2019 | 15 | Main Document (19) Docket Text: PROPOSED Scheduling Order, by Genentech, Inc., InterMune, Inc.. (Attachments: # (1) Letter)(Jacobs, Karen) Modified on 8/30/2019 (nms). |
| Aug 30, 2019 | 15 | Cover Letter (1) |
| Aug 30, 2019 | 15 | Proposed Order (19) |
| Aug 20, 2019 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 8/20/2019. Local counsel present for plaintiffs: J. Blumenfeld. Local counsel present for defendants: S. Brauerman, A. Orlacchio, S. O'Byrne, S. Stamoulis, A. Gaza, E. Ormerod, B. Schladweiler, J. Parshall, M. Haney, K. Dorsney. (Court Reporter Heather Triozzi.) Associated Cases: 1:19-cv-00078-RGA et al.(crb) |
| Aug 16, 2019 | 14 | Main Document (26) Docket Text: PROPOSED Scheduling Order, by Genentech, Inc., InterMune, Inc.. (Attachments: # (1) Letter)(Jacobs, Karen) Modified on 8/20/2019 (nms). |
| Aug 16, 2019 | 14 | Letter to The Honorable Richard G. Andrews (2) |
| Aug 16, 2019 | 14 | Proposed Order (26) |
| May 16, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER SETTING RULE 16(b) CONFERENCE: A scheduling conference pursuant to Fed. R. Civ. P. 16(b) will be held on Tuesday, August 20, 2019, at 2:30 p.m., in Courtroom 6A of the Boggs Federal Building, 844 King Street, Wilmington, Delaware. Plaintiffs counsel shall coordinate a dial in number for all parties wishing to participate, but not physically being able to do so. The dial in number will be for listening capacity only. Parties shall confer about scheduling and discovery limitations, and attempt to reach agreement. The parties shall use as a basis for discussion the Courts Rule 16 Scheduling Order patent, available on the Courts website. No later than 48 hours before the scheduling conference, the parties shall file a proposed scheduling order using the Rule 16 Scheduling Order - patent. The parties shall direct any requests or questions regarding the scheduling or management of this case to the Courts Case Manager at (302) 573-6137. Ordered by Judge Richard G. Andrews on 5/16/2019. Associated Cases: 1:19-cv-00078-RGA et al.(nms) |
| Apr 11, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Ronald M. Daignault and Richard Juang for Aizant Drug Research Solutions Pvt. Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Apr 8, 2019 | 12 | Answer to Counterclaim (30) Docket Text: ANSWER to [9] Answer to Complaint, Counterclaim by Genentech, Inc., InterMune, Inc..(Jacobs, Karen) |
| Mar 27, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [11] MOTION for Pro Hac Vice Appearance of Attorney Ronald M. Daignault and Richard Juang, filed by Aizant Drug Research Solutions Pvt. Ltd.. Signed by Judge Richard G. Andrews on 3/27/2019. (nms) |
| Mar 26, 2019 | 11 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Ronald M. Daignault and Richard Juang - filed by Aizant Drug Research Solutions Pvt. Ltd.. (Stamoulis, Stamatios) |
| Mar 18, 2019 | 10 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Aizant Drug Research Solutions Pvt. Ltd.. (Stamoulis, Stamatios) |
| Mar 18, 2019 | 9 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, and COUNTERCLAIMS against Genentech, Inc., InterMune, Inc., by Aizant Drug Research Solutions Pvt. Ltd..(Stamoulis, Stamatios) Modified on 3/19/2019 (nms). |
| Mar 8, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Feb 21, 2019 | N/A | SO ORDERED (0) |
| Feb 19, 2019 | 8 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to answer or otherwise respond to the Complaint to Mach 18, 2019 - filed by Aizant Drug Research Solutions Pvt. Ltd.. (Stamoulis, Stamatios) |
| Feb 12, 2019 | N/A | SO ORDERED (0) |
| Feb 11, 2019 | 7 | Motion for Leave to Appear Pro Hac Vice (15) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Mark E. Waddell, Warren K. MacRae and Ryan Hagglund of LOEB & LOEB LLP - filed by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) |
| Feb 6, 2019 | 6 | Affidavit of Service (9) Docket Text: AFFIDAVIT of Service for Complaint and related papers served on Aizant Drug Research Solutions Pvt. Ltd. on February 5, 2019, filed by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) |
| Feb 6, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:19-cv-00177-RGA, 1:19-cv-00178-RGA, 1:19-cv-00190-RGA, 1:19-cv-00195-RGA, 1:19-cv-00202-RGA, 1:19-cv-00203-RGA, 1:19-cv-00205-RGA, 1:19-cv-00219-RGA, 1:19-cv-00223-RGA (rjb) |
| Feb 4, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Aizant Drug Research Solutions Pvt. Ltd. on 2/4/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (rwc) |
| Feb 1, 2019 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Genentech, Inc. for InterMune, Inc.; Corporate Parent Roche Holding Ltd., Corporate Parent Novartis Ltd., Corporate Parent Roche Holdings, Inc. for Genentech, Inc. filed by Genentech, Inc., InterMune, Inc. (rwc) |
| Feb 1, 2019 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,566,729 B1 ;7,635,707 B1 ;7,767,700 B2 ;7,816,383 B1 ;7,910,610 B1. (rwc) |
| Feb 1, 2019 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/22/18. Date of Expiration of Patent: 9/22/26 through 8/30/33.Thirty Month Stay Deadline: 8/15/2022. (rwc) |
| Feb 1, 2019 | 1 | Main Document (40) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Aizant Drug Research Solutions Pvt. Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2560144.) - filed by InterMune, Inc., Genentech, Inc. (Attachments: # (1) Exhibit 1-15, # (2) Civil Cover Sheet)(rwc) |
| Feb 1, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc) |
| Feb 1, 2019 | 1 | Civil Cover Sheet (3) |
| Feb 1, 2019 | 1 | Exhibit 1-15 (217) |
| Feb 1, 2019 | 1 | Complaint* (1) |
